Literature DB >> 7115350

A study of highly purified mucolipidosis III urinary N-acetyl-beta-D-hexosaminidase B.

S Hirani, L Little, A L Miller.   

Abstract

Highly purified N-acetyl-beta-D-hexosaminidase B from normal urine and urine of a patient with mucolipidosis III was used to determine whether it has undergone any of the alterations associated with this genetic defect. Examination by sodium dodecyl sulphate/polyacrylamide gel electrophoresis showed that both the enzyme preparations contained protein components with apparent Mr values of 55 000 and 28 000. No differences in the binding and apparent KI (50%) to concanavalin A of the normal and mucolipidosis III enzymes were detected. However, the patient's N-acetyl-beta-D-hexosaminidase B had a slightly greater affinity for the lectin from Ricinus communis than did the normal enzyme. Two-dimensional tryptic peptide maps of the corresponding normal and the patient's N-acetyl-beta-D-hexosaminidase B subunits showed considerable homology. These results indicate that N-acetyl-beta-D-hexosaminidase b does not undergo the significant carbohydrate alterations characteristic of other acid hydrolases in mucolipidosis III.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115350      PMCID: PMC1158385          DOI: 10.1042/bj2040557

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  The subunits of human hexosaminidase A.

Authors:  E Beutler; A Yoshida; W Kuhl; J E Lee
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

2.  Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein.

Authors:  J H Elder; R A Pickett; J Hampton; R A Lerner
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

3.  The substrate specificities of endo-beta-N-acetylglucosaminidases CII and H.

Authors:  T Tai; K Yamashita; A Kobata
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

4.  "I-cell" disease: leakage of lysosomal enzymes into extracellular fluids.

Authors:  U Wiesmann; F Vassella; N Herschkowitz
Journal:  N Engl J Med       Date:  1971-11-04       Impact factor: 91.245

5.  Multiple lysosomal enzyme deficiency due to enzyme leakage?

Authors:  U N Wiesmann; J Lightbody; F Vassella; N N Herschkowitz
Journal:  N Engl J Med       Date:  1971-01-14       Impact factor: 91.245

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Enzymatic phosphorylation of lysosomal enzymes in the presence of UDP-N-acetylglucosamine. Absence of the activity in I-cell fibroblasts.

Authors:  A Hasilik; A Waheed; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

8.  Demonstration of altered acidic hydrolases in fibroblasts from patients with mucolipidosis II by lectin titration.

Authors:  R Rousson; Y Ben-Yoseph; M B Fiddler; H L Nadler
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

9.  N-Acetyl-beta-glucosaminidases in human spleen.

Authors:  D Robinson; J L Stirling
Journal:  Biochem J       Date:  1968-04       Impact factor: 3.857

10.  Carbohydrate composition of human placental N-acetylhexosaminidase A and B.

Authors:  H Freeze; B Geiger; A L Miller
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

View more
  2 in total

1.  Molecular forms of beta-hexosaminidase and cathepsin D in serum and urine of healthy subjects and patients with elevated activity of lysosomal enzymes.

Authors:  M Zühlsdorf; M Imort; A Hasilik; K von Figura
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

2.  Mucolipidosis III beta-N-acetyl-D-hexosaminidase A. Purification and properties.

Authors:  B C Kress; S Hirani; H H Freeze; L Little; A L Miller
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.